J. Katagi

发表

Utility of human hepatocyte spheroids for evaluation of hepatotoxicity

H. Arakawa, T. Ueda, M. Kakiki, 2015 .

Design, synthesis, and biological evaluation of novel somatostatin receptor subtype-2 agonists: Optimization for potency and risk mitigation of hERG and phospholipidosis.

T. Maruyama, T. Matsushita, J. Katagi, 2021, Bioorganic & medicinal chemistry.

Why Can dl-Sotalol Prolong the QT Interval In Vivo Despite Its Weak Inhibitory Effect on hERG K+ Channels In Vitro? Electrophysiological and Pharmacokinetic Analysis with the Halothane-Anesthetized Guinea Pig Model

J. Katagi, A. Sugiyama, Kentaro Ando, 2015, Cardiovascular Toxicology.

Evaluation of Using Dogs to Predict Fraction of Oral Dose Absorbed in Humans for Poorly Water-Soluble Drugs.

S. Yamashita, K. Sugano, J. Katagi, 2018, Journal of pharmaceutical sciences.

DEMONSTRATION OF DOCOSAHEXAENOIC ACID AS A BIOAVAILABILITY ENHANCER FOR CYP3A SUBSTRATES: IN VITRO AND IN VIVO EVIDENCE USING CYCLOSPORIN IN RATS

Hitoshi Sato, Hitoshi Sato, J. Katagi, 2006, Drug Metabolism and Disposition.

Coactivation of secretogranin-II and BDNF genes mediated by calcium signals in mouse cerebellar granule cells.

T. Tsuchiya, J. Katagi, A. Tabuchi, 1999, Brain research. Molecular brain research.

Effects of a prostagrandin EP4-receptor agonist ONO-AE1-329 on the left ventricular pressure-volume relationship in the halothane-anesthetized dogs.

J. Katagi, A. Sugiyama, Kentaro Ando, 2016, European journal of pharmacology.

Discovery of new orally active prostaglandin D2 receptor antagonists.

M. Toda, H. Nakai, M. Iwahashi, 2011, Bioorganic & medicinal chemistry.

Why Can dl-Sotalol Prolong the QT Interval In Vivo Despite Its Weak Inhibitory Effect on hERG K+ Channels In Vitro? Electrophysiological and Pharmacokinetic Analysis with the Halothane-Anesthetized Guinea Pig Model

J. Katagi, A. Sugiyama, Kentaro Ando, 2016, Cardiovascular Toxicology.